Exclusive

Publication

Byline

First Mounjaro, now Yurpeak: Eli Lilly ties up with Cipla to bring weight loss drug under new name

New Delhi, Oct. 23 -- US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India's booming m... Read More


Biocon Biologics eyes expansion in the US insulin market

New Delhi, Oct. 22 -- Biocon Biologics Ltd is aiming to expand its insulin portfolio in the US market, as global innovators focus on more lucrative anti-obesity GLP-1 therapies. Biocon Ltd's biosimil... Read More


Pharma Q2 preview: Steady growth despite US sales pressure, GST rate cuts

New Delhi, Oct. 21 -- Indian drugmakers are expected to post steady earnings growth for the quarter ended 30 September, gaining from continued traction across global markets, although domestic sales m... Read More


Mint Explainer: The US Biosecure Act is back. How will Indian contract manufacturers benefit?

New Delhi, Oct. 13 -- A piece of US legislation from 2024 that aimed to curb American companies' ties to certain Chinese biotechs has made a comeback - and Indian contract drug manufacturers are prime... Read More


Pharma deals are surging. But the biggest drugmakers are holding back.

New Delhi, Oct. 9 -- Dealmaking in India's pharma sector has surged over the past two years as companies seek to beef up their portfolios and reduce reliance on the US market. Yet, some of the country... Read More


Mint Explainer | Does India have a cough syrup problem?

New Delhi, Oct. 5 -- Two Indian drugmakers have come under regulatory scrutiny after cough syrups made by them were linked to a number of child deaths in Madhya Pradesh and Rajasthan. The central drug... Read More


Glenmark inks $18 million deal for cancer drug with China's Hengrui

New Delhi, Sept. 24 -- Glenmark Pharmaceuticals Ltd on Wednesday announced a licensing deal with Chinese drugmaker Hengrui Pharma for its under-development lung and breast cancer drug. The deal involv... Read More


Mint Explainer: What is Trump's problem with paracetamol?

New Delhi, Sept. 24 -- US President Donald Trump wants to curb rising autism diagnoses, and has turned his sights on a popular over-the-counter (OTC) painkiller-Tylenol. On 22 September, Trump, alongs... Read More


Mint Explainer: Are Trump's claims about painkiller Tylenol unfounded?

New Delhi, Sept. 24 -- US President Donald Trump wants to curb rising autism diagnoses, and has turned his sights on a popular over-the-counter (OTC) painkiller-Tylenol. On 22 September, Trump, alongs... Read More


Why Metropolis Healthcare is banking on acquisitions to fuel growth

New Delhi, Sept. 23 -- After aggressive organic expansion between FY21 and FY25, when it added nearly 90 labs and more than doubled its patient service centres from 251 to 530, Metropolis Healthcare L... Read More